8.4 C
New York
Saturday, July 27, 2024

COVID-19 vaccine: Nigeria hopes to get 42m doses through COVAX scheme

Published:

LATEST NEWS

- Advertisement -

The National Primary Health Care Development Agency (NPHCDA) says Nigeria hopes to get 42 million doses of COVID-19 vaccine soon to cover one fifth of its population.

The Executive Director, NPHCDA, Dr Faisal Shuaib, disclosed this at the Presidential Task Force briefing on COVID-19, on Tuesday in  Abuja.

Shuaib said that the vaccine would be got through the global COVAX scheme.

He said that the initial doses would come as part of Nigeria’s plan to inoculate 40 per cent of the population in 2021.

“The COVAX scheme was set up to provide vaccines to poorer countries such as Nigeria, whose 200 million people and poor infrastructure pose a daunting challenge to medical officials rolling out the vaccinations, as the West African country battles a second, larger spike in coronavirus cases.

READ ALSO  Reps begins probe into missing crude, dirty fuel

“Nigeria, where officials recorded low coronavirus numbers through much of 2020, had 1,204 new cases on Monday, its highest ever, as total confirmed cases edge closer to 100,000.

“Nigeria will first inoculate frontline health workers, first responders, national leaders, people vulnerable to coronavirus and the elderly,“ he said.

He said that Nigeria must educate its citizens on the importance of COVID-19 vaccination.

“We fear what we don’t understand,” he  noted.

- Advertisement -spot_img

Hey there! Exciting news - we've deactivated our website's comment provider to focus on more interactive channels! Join the conversation on our stories through Facebook, Twitter, and other social media pages, and let's chat, share, and connect in the best way possible!

Join our social media

For even more exclusive content!

Of The Week
CARTOON

TOP STORIES

- Advertisement -spot_img
- Advertisement -

Of The Week
CARTOON

247Ureports Protects its' news articles from plagiarism as an important part of maintaining the integrity of our website.